{"id":"https://openalex.org/W2016016176","doi":"https://doi.org/10.3109/02841860903268031","title":"Gemcitabine and capecitabine in combination for advanced anthracycline and taxane pre-treated breast cancer patients: A phase II study","display_name":"Gemcitabine and capecitabine in combination for advanced anthracycline and taxane pre-treated breast cancer patients: A phase II study","publication_year":2009,"publication_date":"2009-10-20","ids":{"openalex":"https://openalex.org/W2016016176","doi":"https://doi.org/10.3109/02841860903268031","mag":"2016016176","pmid":"https://pubmed.ncbi.nlm.nih.gov/19839920"},"language":"en","primary_location":{"id":"doi:10.3109/02841860903268031","doi":"https://doi.org/10.3109/02841860903268031","is_oa":true,"landing_page_url":"https://doi.org/10.3109/02841860903268031","pdf_url":"https://www.tandfonline.com/doi/pdf/10.3109/02841860903268031?needAccess=true","source":{"id":"https://openalex.org/S1043257","display_name":"Acta Oncologica","issn_l":"0284-186X","issn":["0284-186X","1651-226X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Oncologica","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://www.tandfonline.com/doi/pdf/10.3109/02841860903268031?needAccess=true","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5065355046","display_name":"Annika Malmstr\u00f6m","orcid":"https://orcid.org/0000-0001-8410-4939","observed_orcids":["https://orcid.org/0000-0001-8410-4939"]},"institutions":[{"id":"https://openalex.org/I4210151885","display_name":"Link\u00f6ping University Hospital","ror":"https://ror.org/05h1aye87","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I4210151885"]}],"countries":["SE"],"is_corresponding":true,"raw_author_name":"Annika Malmstr\u00f6m","raw_affiliation_strings":["Unit of Advanced Palliative Home Care, Link\u00f6ping University Hospital, Link\u00f6ping, Sweden. annika.malmstrom@lio.se","Unit of Advanced Palliative Home Care, Link\u00f6ping University Hospital, Link\u00f6ping, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Unit of Advanced Palliative Home Care, Link\u00f6ping University Hospital, Link\u00f6ping, Sweden. annika.malmstrom@lio.se","institution_ids":["https://openalex.org/I4210151885"]},{"raw_affiliation_string":"Unit of Advanced Palliative Home Care, Link\u00f6ping University Hospital, Link\u00f6ping, Sweden","institution_ids":["https://openalex.org/I4210151885"]}]},{"author_position":"middle","author":{"id":null,"display_name":"J\u00f6rgen Hansen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210119959","display_name":"Karlstad Central Hospital","ror":"https://ror.org/02kwcpg86","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I4210119959"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"J\u00f6rgen Hansen","raw_affiliation_strings":["Department of Oncology, Central Hospital, Karlstad, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Central Hospital, Karlstad, Sweden","institution_ids":["https://openalex.org/I4210119959"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006055583","display_name":"Lena Malmberg","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210148116","display_name":"Ryhov Hospital J\u00f6nk\u00f6ping","ror":"https://ror.org/053xhbr86","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I4210148116"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Lena Malmberg","raw_affiliation_strings":["Department of Oncology, Ryhov Hospital, J\u00f6nk\u00f6ping, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Ryhov Hospital, J\u00f6nk\u00f6ping, Sweden","institution_ids":["https://openalex.org/I4210148116"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056446861","display_name":"Lena M. S. Carlsson","orcid":"https://orcid.org/0000-0003-4145-6242","observed_orcids":["https://orcid.org/0000-0003-4145-6242"]},"institutions":[{"id":"https://openalex.org/I2800044222","display_name":"Sundsvall Municipality","ror":"https://ror.org/05edmwq13","country_code":"SE","type":"government","lineage":["https://openalex.org/I2800044222"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Lena Carlsson","raw_affiliation_strings":["Department of Oncology, County Hospital, Sundsvall, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, County Hospital, Sundsvall, Sweden","institution_ids":["https://openalex.org/I2800044222"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110263192","display_name":"Jan-Henry Svensson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801112325","display_name":"Sahlgrenska University Hospital","ror":"https://ror.org/04vgqjj36","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I2801112325"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Jan-Henry Svensson","raw_affiliation_strings":["Department of Oncology, Sahlgrenska University Hospital, G\u00f6teborg, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Sahlgrenska University Hospital, G\u00f6teborg, Sweden","institution_ids":["https://openalex.org/I2801112325"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048816555","display_name":"Johan Ahlgren","orcid":"https://orcid.org/0000-0001-6392-273X","observed_orcids":["https://orcid.org/0000-0001-6392-273X"]},"institutions":[{"id":"https://openalex.org/I4210142144","display_name":"G\u00e4vle Hospital","ror":"https://ror.org/04esjnq02","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I4210142144"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Johan Ahlgren","raw_affiliation_strings":["Department of Oncology, County Hospital, G\u00e4vle, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, County Hospital, G\u00e4vle, Sweden","institution_ids":["https://openalex.org/I4210142144"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053115455","display_name":"Cecila Ahlin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210129463","display_name":"\u00d6rebro University Hospital","ror":"https://ror.org/02m62qy71","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I4210129463"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Cecila Ahlin","raw_affiliation_strings":["Department of Oncology, \u00d6rebro University Hospital, Sweden","Department of Oncology, Orebro University Hospital, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, \u00d6rebro University Hospital, Sweden","institution_ids":["https://openalex.org/I4210129463"]},{"raw_affiliation_string":"Department of Oncology, Orebro University Hospital, Sweden","institution_ids":["https://openalex.org/I4210129463"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087362691","display_name":"Tomas E. Jansson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210104358","display_name":"St Olav's University Hospital","ror":"https://ror.org/01a4hbq44","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I4210104358"]}],"countries":["NO"],"is_corresponding":false,"raw_author_name":"Tomas Jansson","raw_affiliation_strings":["Department of Oncology, Trondheim University Hospital, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Trondheim University Hospital, Norway","institution_ids":["https://openalex.org/I4210104358"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5087662577","display_name":"Ronny Westberg","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ronny Westberg","raw_affiliation_strings":["RW Clinical Research, Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"RW Clinical Research, Stockholm, Sweden","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":8,"corresponding_author_ids":["https://openalex.org/A5065355046"],"corresponding_institution_ids":["https://openalex.org/I4210151885"],"apc_list":null,"apc_paid":null,"fwci":0.6954,"has_fulltext":true,"cited_by_count":11,"citation_normalized_percentile":{"value":0.72829804,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"49","issue":"1","first_page":"35","last_page":"41"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.9564999938011169,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.9564999938011169,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.029100000858306885,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.006099999882280827,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gemcitabine","display_name":"gemcitabine","score":0.9950000047683716},{"id":"https://openalex.org/keywords/capecitabine","display_name":"capecitabine","score":1.0},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.9259999990463257},{"id":"https://openalex.org/keywords/anthracycline-refractory-disease","display_name":"anthracycline-refractory disease","score":0.7760000228881836},{"id":"https://openalex.org/keywords/taxane-refractory-disease","display_name":"taxane-refractory disease","score":0.9980000257492065},{"id":"https://openalex.org/keywords/second-line-chemotherapy","display_name":"second-line chemotherapy","score":0.7239999771118164},{"id":"https://openalex.org/keywords/time-to-progression","display_name":"time to progression","score":0.8610000014305115},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.8539999723434448},{"id":"https://openalex.org/keywords/hand-foot-syndrome","display_name":"hand-foot syndrome","score":0.722000002861023},{"id":"https://openalex.org/keywords/granulocytopenia","display_name":"granulocytopenia","score":0.9409999847412109},{"id":"https://openalex.org/keywords/palliative-care","display_name":"palliative care","score":0.6790000200271606},{"id":"https://openalex.org/keywords/combination-chemotherapy-toxicity","display_name":"combination chemotherapy toxicity","score":0.7590000033378601},{"id":"https://openalex.org/keywords/fatigue","display_name":"fatigue","score":0.3569999933242798},{"id":"https://openalex.org/keywords/response-rate","display_name":"response rate","score":0.48899999260902405},{"id":"https://openalex.org/keywords/stable-disease","display_name":"stable disease","score":0.7170000076293945},{"id":"https://openalex.org/keywords/neutropenic-infection","display_name":"neutropenic infection","score":0.5239999890327454}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9602583050727844},{"id":"https://openalex.org/C2777909004","wikidata":"https://www.wikidata.org/wiki/Q420207","display_name":"Capecitabine","level":4,"score":0.9199262857437134},{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.7995363473892212},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.6929906606674194},{"id":"https://openalex.org/C2777511904","wikidata":"https://www.wikidata.org/wiki/Q425227","display_name":"Taxane","level":4,"score":0.6862980127334595},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6653422117233276},{"id":"https://openalex.org/C2778822529","wikidata":"https://www.wikidata.org/wiki/Q1951525","display_name":"Progressive disease","level":3,"score":0.586811900138855},{"id":"https://openalex.org/C2776802502","wikidata":"https://www.wikidata.org/wiki/Q417589","display_name":"Anthracycline","level":4,"score":0.5746810436248779},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5679459571838379},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.5361298322677612},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5066076517105103},{"id":"https://openalex.org/C2779984678","wikidata":"https://www.wikidata.org/wiki/Q2145898","display_name":"Response Evaluation Criteria in Solid Tumors","level":4,"score":0.486774206161499},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4856666326522827},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4156450033187866},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.40532368421554565},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.06725281476974487}],"mesh":[{"descriptor_ui":"D000069287","descriptor_name":"Capecitabine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000093542","descriptor_name":"Gemcitabine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016879","descriptor_name":"Salvage Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018943","descriptor_name":"Anthracyclines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D043823","descriptor_name":"Taxoids","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D053208","descriptor_name":"Kaplan-Meier Estimate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.3109/02841860903268031","doi":"https://doi.org/10.3109/02841860903268031","is_oa":true,"landing_page_url":"https://doi.org/10.3109/02841860903268031","pdf_url":"https://www.tandfonline.com/doi/pdf/10.3109/02841860903268031?needAccess=true","source":{"id":"https://openalex.org/S1043257","display_name":"Acta Oncologica","issn_l":"0284-186X","issn":["0284-186X","1651-226X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Oncologica","raw_type":"journal-article"},{"id":"pmid:19839920","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19839920","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta oncologica (Stockholm, Sweden)","raw_type":"Clinical Trial, Phase II"}],"best_oa_location":{"id":"doi:10.3109/02841860903268031","doi":"https://doi.org/10.3109/02841860903268031","is_oa":true,"landing_page_url":"https://doi.org/10.3109/02841860903268031","pdf_url":"https://www.tandfonline.com/doi/pdf/10.3109/02841860903268031?needAccess=true","source":{"id":"https://openalex.org/S1043257","display_name":"Acta Oncologica","issn_l":"0284-186X","issn":["0284-186X","1651-226X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Oncologica","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2016016176.pdf","grobid_xml":"https://content.openalex.org/works/W2016016176.grobid-xml"},"referenced_works_count":13,"referenced_works":["https://openalex.org/W5038423","https://openalex.org/W1984254136","https://openalex.org/W2021371461","https://openalex.org/W2051804590","https://openalex.org/W2068117832","https://openalex.org/W2084095038","https://openalex.org/W2086140322","https://openalex.org/W2115428190","https://openalex.org/W2131770017","https://openalex.org/W2139977268","https://openalex.org/W2159329940","https://openalex.org/W2242556880","https://openalex.org/W2589931982"],"related_works":["https://openalex.org/W2103500800","https://openalex.org/W2090693190","https://openalex.org/W2051804590","https://openalex.org/W2385489098","https://openalex.org/W5038423","https://openalex.org/W2359152349","https://openalex.org/W2270618595","https://openalex.org/W2242556880","https://openalex.org/W1852032","https://openalex.org/W2133804515"],"abstract_inverted_index":{"AIM:":[0],"The":[1,75,122,191,221,257],"aim":[2],"of":[3,12,77,142,148,159,216,241,244,253,267,292,298,305],"this":[4],"study":[5,255],"was":[6,101,125,177,197,212,227,249,261,320,325],"to":[7,71,104,118,126,129,173,189,195,199,207],"explore":[8],"the":[9,54,105,119,140,186,203,254,303,306,323,331],"clinical":[10],"value":[11,304],"gemcitabine":[13],"combined":[14],"with":[15,22,47,136,263],"capecitabine":[16,62],"(GC)":[17],"in":[18,97,214,230,236,251],"heavily":[19],"pre-treated":[20],"patients":[21,30,38,78,143,161,219,226,268],"metastatic":[23,43,88],"breast":[24,315],"cancer.":[25],"MATERIAL":[26],"AND":[27],"METHODS:":[28],"All":[29,164],"had":[31],"failed":[32],"anthracyclines":[33],"and":[34,50,61,154,171,202,265,294,322],"taxanes.":[35],"In":[36],"14":[37],"(41%),":[39],"more":[40,245],"than":[41,246],"two":[42],"sites":[44],"were":[45,68,92,112,133,162,282],"diagnosed":[46],"bone":[48],"(68%)":[49],"liver":[51],"(62%)":[52],"being":[53],"most":[55],"prominent.":[56],"Gemcitabine":[57],"(1,250":[58],"mg/m(2),":[59],"d1+8)":[60],"(800":[63],"mg/m(2)":[64],"twice":[65],"daily,":[66],"d1-14)":[67],"administered":[69],"according":[70,103,117],"a":[72,310],"3-week":[73],"schedule.":[74],"majority":[76],"received":[79],"GC":[80,307,332],"as":[81,309],"3rd":[82],"or":[83,146,184,233,273],"4th":[84],"line":[85],"chemotherapy":[86],"for":[87,168,312],"disease.":[89],"Laboratory":[90],"tests":[91],"done":[93,113],"on":[94,139],"day":[95],"1+8":[96],"cycles.":[98],"Subjective":[99],"toxicity":[100,153,183],"recorded":[102],"NCI-CTC":[106],"v.":[107],"2.0":[108],"criteria.":[109,121],"Tumour":[110,318],"evaluations":[111],"every":[114],"12th":[115],"week":[116],"RECIST":[120],"primary":[123],"objective":[124],"investigate":[127],"time":[128,172,194,206],"progression.":[130],"Secondary":[131],"objectives":[132],"response":[134,170,211],"rate":[135],"special":[137],"focus":[138],"proportion":[141],"achieving":[144],"PR":[145],"SD":[147],"at":[149],"least":[150],"three":[151,247],"months,":[152],"survival.":[155],"RESULTS:":[156],"A":[157,239],"total":[158],"34":[160],"enrolled.":[163],"subjects":[165],"are":[166],"eligible":[167],"toxicity,":[169],"event":[174],"analyses.":[175],"Treatment":[176],"given":[178],"until":[179,185],"progressive":[180],"disease,":[181],"severe":[182],"patient":[187],"wanted":[188],"withdraw.":[190],"Kaplan-Meier":[192],"median":[193],"progression":[196,235,243,319],"estimated":[198],"4.3":[200],"months":[201,248],"overall":[204],"survival":[205],"13.7":[208],"months.":[209],"Partial":[210],"noted":[213,250],"12":[215],"29":[217],"evaluable":[218],"(41%).":[220],"best":[222],"outcome":[223],"amongst":[224],"remaining":[225],"stable":[228],"disease":[229,242],"nine":[231],"(31%)":[232],"tumour":[234],"eight":[237],"(28%).":[238],"delay":[240],"53%":[252],"population.":[256],"main":[258],"side":[259],"effect":[260],"granulocytopenia":[262],"44%":[264],"15%":[266],"suffering":[269],"from":[270],"grade":[271,274,285],"3":[272,286],"4":[275],"events":[276],"respectively":[277],"however,":[278],"no":[279],"neutropenic":[280],"infections":[281],"observed.":[283],"Pre-dominant":[284],"subjective":[287],"toxicities":[288],"were:":[289],"fatigue":[290],"(21%":[291],"patients)":[293],"hand-foot":[295],"syndrome":[296],"(15%":[297],"patients).":[299],"DISCUSSIONS:":[300],"We":[301,328],"investigated":[302],"combination":[308],"treatment":[311,324],"late":[313],"stage":[314],"cancer":[316],"patients.":[317],"delayed":[321],"well":[326],"tolerated.":[327],"believe":[329],"that":[330],"therapy":[333],"can":[334],"achieve":[335],"meaningful":[336],"palliation.":[337]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}